Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Wirz-Justice, Anna
and
Van den Hoofdakker, Rutger H
1999.
Sleep deprivation in depression: what do we know, where do we go?.
Biological Psychiatry,
Vol. 46,
Issue. 4,
p.
445.
Robinson, Donald S.
and
Rickels, Karl
2000.
Concerns About Clinical Drug Trials.
Journal of Clinical Psychopharmacology,
Vol. 20,
Issue. 6,
p.
593.
Artigas, Francesc
2001.
Limitations to enhancing the speed of onset of antidepressants — are rapid action antidepressants possible?.
Human Psychopharmacology: Clinical and Experimental,
Vol. 16,
Issue. 1,
p.
29.
Pérez, Victor
Puigdemont, Dolors
Gilaberte, Inmaculada
Alvarez, Enric
and
Artigas, Francesc
2001.
Augmentation of Fluoxetine's Antidepressant Action by Pindolol: Analysis of Clinical, Pharmacokinetic, and Methodologic Factors.
Journal of Clinical Psychopharmacology,
Vol. 21,
Issue. 1,
p.
36.
Faries, Douglas E.
Heiligenstein, John H.
Tollefson, Gary D.
and
Potter, William Z.
2001.
The Double-Blind Variable Placebo Lead-in Period: Results From Two Antidepressant Clinical Trials.
Journal of Clinical Psychopharmacology,
Vol. 21,
Issue. 6,
p.
561.
Oxman, Thomas E.
and
Sengupta, Anjana
2002.
Treatment of Minor Depression.
The American Journal of Geriatric Psychiatry,
Vol. 10,
Issue. 3,
p.
256.
Max, Mitchell B.
2002.
Principles and Practice of Clinical Research.
p.
207.
Streiner, David L
2002.
The 2 “Es” of Research: Efficacy and Effectiveness Trials.
The Canadian Journal of Psychiatry,
Vol. 47,
Issue. 6,
p.
552.
Cartwright, Rosalind
Baehr, Erin
Kirkby, Jennifer
Pandi-Perumal, S.R.
and
Kabat, Julie
2003.
REM sleep reduction, mood regulation and remission in untreated depression.
Psychiatry Research,
Vol. 121,
Issue. 2,
p.
159.
Marie-Mitchell, Ariane
Leuchter, Andrew F
Chou, Chih-Ping
James Gauderman, W
and
Azen, Stanley P
2004.
Predictors of improved mood over time in clinical trials for major depression.
Psychiatry Research,
Vol. 127,
Issue. 1-2,
p.
73.
Dworkin, Robert H.
Katz, Jennifer
and
Gitlin, Michael J.
2005.
Placebo response in clinical trials of depression and its implications for research on chronic neuropathic pain.
Neurology,
Vol. 65,
Issue. 12_suppl_4,
Bisaga, Adam
Aharonovich, Efrat
Garawi, Fatima
Levin, Frances R.
Rubin, Eric
Raby, Wilfrid N.
Vosburg, Suzanne K.
and
Nunes, Edward V.
2005.
Utility of lead-in period in cocaine dependence pharmacotherapy trials.
Drug and Alcohol Dependence,
Vol. 77,
Issue. 1,
p.
7.
Vallance, Aaron K.
2006.
Something out of nothing: the placebo effect.
Advances in Psychiatric Treatment,
Vol. 12,
Issue. 4,
p.
287.
MAX, MITCHELL B.
2007.
Principles and Practice of Clinical Research.
p.
219.
Lakoff, Andrew
2007.
The Right Patients for the Drug: Managing the Placebo Effect in Antidepressant Trials.
BioSocieties,
Vol. 2,
Issue. 1,
p.
57.
Sackeim, Harold A.
Brannan, Stephen K.
Rush, A. John
George, Mark S.
Marangell, Lauren B.
and
Allen, John
2007.
Durability of antidepressant response to vagus nerve stimulation (VNS).
The International Journal of Neuropsychopharmacology,
Vol. 10,
Issue. 06,
Boulenger, J.-P.
2007.
Traitements antidépresseurs : critères d’évaluation du résultat thérapeutique.
L'Encéphale,
Vol. 33,
Issue. 4,
p.
666.
Hunter, A. M.
Ravikumar, S.
Cook, I. A.
and
Leuchter, A. F.
2009.
Brain functional changes during placebo lead‐in and changes in specific symptoms during pharmacotherapy for major depression.
Acta Psychiatrica Scandinavica,
Vol. 119,
Issue. 4,
p.
266.
Cipriani, Andrea
and
Geddes, John R.
2010.
What is a run-in phase?.
Epidemiologia e Psichiatria Sociale,
Vol. 19,
Issue. 1,
p.
21.
Stoney, Catherine M.
and
Lee Johnson, Laura
2012.
Principles and Practice of Clinical Research.
p.
225.
eLetters
No eLetters have been published for this article.